Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes

This publication has 22 references indexed in Scilit:

• Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
  Diabetologia, 2014
• Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications
  Microvascular Research, 2014
• Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria 血浆晚期蛋白氧化产物浓度升高是无白蛋白尿的2型糖尿病患者内皮细胞功能异常的早期标志物
  Journal of Diabetes, 2014
• Advanced Glycation End Products and Diabetic Complications
  The Korean Journal of Physiology & Pharmacology, 2014
• Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
  Current Diabetes Reports, 2013
• Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men
  Archives of internal medicine (1960), 2011
• Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet
  Journal of the American Dietetic Association, 2010
• Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008
• The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
  Analytical Biochemistry, 1996
• Advanced oxidation protein products as a novel marker of oxidative stress in uremia
  Kidney International, 1996